(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile/1191237-69-0

Product Name：(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile

Usage: Remdesivir intermediate (development code GS-5734) is a novel antiviral drug in the class of nucleotide analogs, used in treatment of COVID-19.

Chemical Name: (2R,3R,4S,5R)-2-(4-aminopyrrolo[1,2-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile;(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triChemicalbookazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile(GS-441524);D-Altrononitrile,2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-;GS441525

CAS No.: 1191237-69-0

Molecular Formula: C₁₂H₁₃N₅O₄
Molecular Weight: 291.26

Specifications: 

Appearance: White to yellow  solid;

Purity: 98.0%min

Based on success against other coronavirus infections, Gilead provided remdesivir to physicians who treated an American patient in Snohomish County, Washington in 2020, infected with SARS-CoV-2 and is providing the compound to China to conduct a pair of trials in infected individuals with and without severe symptoms.